Scotland issues new framework to help reduce the risk of developing type 2 diabetes

Scotland issues new framework to help reduce the risk of developing type 2 diabetes

July 20 2018 A new framework emphasising weight management as part of the drive to reduce the...

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

July 19 2018 The medicines regulator has issued a Drug Safety Update relating to suspected...

APPG calls for long term conditions to be part of new pharmacy contract

APPG calls for long term conditions to be part of new pharmacy contract

July 16 2018 Community pharmacy’s involvement in managing long term conditions should be...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

RPS seeks views on draft guidance around polypharmacy

RPS seeks views on draft guidance around polypharmacy

July 13 2018 The Royal Pharmaceutical Society is seeking comments to hone draft guidance on...

  • Scotland issues new framework to help reduce the risk of developing type 2 diabetes

    Scotland issues new framework to help reduce the risk of developing type 2 diabetes

    Friday, 20 July 2018 14:36
  • MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    MHRA issues reminder to use Yellow Card reporting for suspected ADRs associated with pregnancy

    Thursday, 19 July 2018 10:29
  • APPG calls for long term conditions to be part of new pharmacy contract

    APPG calls for long term conditions to be part of new pharmacy contract

    Monday, 16 July 2018 15:44
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:51
  • RPS seeks views on draft guidance around polypharmacy

    RPS seeks views on draft guidance around polypharmacy

    Friday, 13 July 2018 12:47

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

A Resized Diabetes Image cbAugust 3 2017

Prescribing for diabetes medicines in England increased 80.1% over the past decade, when overall prescribing item numbers increased only 46.0%. In the past year alone, total diabetes prescription items grew at 4.7% compared to total prescription item growth of 2.0%

The figures come in a new report from NHS Digital, ‘Prescribing for Diabetes: England 2006-07 to 2016-17’. Some “52.0 million items were prescribed for diabetes in 2016-17, up from 49.7 million in 2015-16, and 28.9 million in 2006-07,” it said.

Based on available data, primary care prescribing for diabetes has increased 40.0% between 2009-10 and 2016-17, whereas recorded diabetes prevalence only increased 22%. The report points out that metformin prescribing rose 51.1%.

Simon O’Neill, Director of Health Intelligence for Diabetes UK, commented: “The number of people diagnosed with diabetes has risen by 54% in the last decade, so it’s no surprise that levels of prescribing have risen by almost the same level.

“But the increase in prescribing at a primary care level is indicative of the hard work doctors are doing to help people living with diabetes keep their blood glucose at safe levels, and preventing devastating, and costly, complications – such as cardiovascular and kidney disease – further down the line.”

Links:
NHS Digital announcement       
NHS analysis       
Diabetes UK statement 

Practice News

July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...